Heather Rees - 27 Jun 2024 Form 4 Insider Report for ATOSSA THERAPEUTICS, INC. (ATOS)

Role
SVP, Finance and Accounting
Signature
/s/ Heather Rees
Issuer symbol
ATOS
Transactions as of
27 Jun 2024
Transactions value $
$0
Form type
4
Filing time
01 Jul 2024, 16:00:09 UTC
Previous filing
16 Oct 2023
Next filing
16 May 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATOS Stock Option (right to buy) Award $0 +578K $0.00 578K 27 Jun 2024 Common Stock 578K $1.05 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options shall vest on a quarterly basis over 24 months following June 27, 2024, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date. The options were issued at approximately 9:30 a.m. (ET) on June 27, 2024, with an exercise price of $1.05, representing the most recently reported closing stock price on June 26, 2024.